Abstract

Objective To study the effect of behavioral therapy combined with Paroxetine in the treatment of overactive bladder accompanied by depression and anxiety. Methods Over the past two years, a total of 69 cases of patients with overactive bladder accompanied by depression and anxiety were diagnosed by outpatient, they were divided into experimental group (n=33)and control group(n=36). The experimental group were given behavior therapy and Paroxetine in the treatment of anxiety, depression, while the control group were given behavior therapy. Then the overactive bladder symptom score(OABSS), urgency score, SDS, SAS score before and after treatment of the two groups of patients were statistically analyzed. Results (1)The OABSS score((3.30±1.01) vs (7.51±0.69)), urgency score((2.60±0.51) vs (3.93±0.69)), SDS score((43.1±6.2) vs (66.4±4.7)) and SAS score((41.9±0.6) vs (61.4±3.9)) decreased after treatment of the experimental group.There were statistically significant compared with before treatment(t=17.8773, 8.9045, 17.2039, 16.0273, all P 0.05) (3)The OABSS score, urgency score, of the experimental group were more depressed than the control group, which were statistically significant(t=3.3830, 3.6391, both P<0.01). Conclusion For overactive bladder patients with anxiety and depression, behavioral therapy combined with Paroxetine is better than behavioral therapy alone. Key words: Behavioral therapy; Paroxetine; Overactive bladder; Depression; Anxiety

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.